Speaker illustration

Professor Stefan Agewall

University of Oslo, Oslo (Norway)

Member of:

European Society of Cardiology
EAPCI
Heart Failure Association

COVID-19 and cardiovascular pharmacotherapy

Event: ESC Congress 2021 - The Digital Experience

Topic: Cardiovascular Pharmacotherapy

Session type: Abstract Sessions

Thumbnail

Launch of new Oxford Master’s in Clinical Trials

Event: ESC CONGRESS 2019

Topic: European Society of Cardiology

Session type: Professional Development

Thumbnail

Adherence to medication and CV outcomes

Event: ESC Congress 2018

Topic: Cardiovascular Pharmacotherapy

Session type: Symposium

Thumbnail

Antiplatelet therapy in PCI

Event: ESC Congress 2018

Topic: Cardiovascular Pharmacotherapy

Session type: Advances in Science

Thumbnail

Expert Advice - Drug prescription in the elderly

Event: ESC Congress 2018

Topic: Cardiovascular Pharmacotherapy

Session type: Expert Session

Thumbnail

Pharmacological treatment of Takotsubo cardiomyopathy

Event: ESC CONGRESS 2017

Topic: Drug therapy

Session type: Symposium

Thumbnail

The use of oral anticoagulants in special situations

Event: ESC CONGRESS 2017

Topic: Drug therapy

Session type: Symposium

Thumbnail

Reversal of NOACs' effect: when and how?

Event: ESC CONGRESS 2016

Topic: Drug therapy

Session type: Symposium

Thumbnail

A perspective on the effects of Empaglifozin in cardiovascular outcomes

Event: ESC CONGRESS 2016

Topic: Drug therapy

Session type: Advances in Science

Thumbnail

Improving secondary prevention of atherosclerotic disease

Event: ESC CONGRESS 2016

Topic: Primary cardiovascular prevention: interventions and outcomes

Session type: Symposium

Thumbnail

This platform is supported by

logo Novo Nordisk